Today: 30 October 2025
27 January 2022
1 min read

Pfizer gets EU nod for Covid-19 pill

The EMA said it had evaluated data from a study involving patients with COVID-19, which showed that treatment with Paxlovid significantly reduced the risk of hospitalization…reports Asian Lite News

 The European Medicines Agency (EMA) has conditionally approved the use of US multinational biotechnology firm Pfizer’s Covid-19 pill for treating adults at risk of severe illness.

The endorsement allows the member states of the European Union (EU) to deploy the drug after the EMA gave guidance for its emergency use late in 2021, Xinhua news agency reported.

The EMA said in a statement that its Committee for Medicinal Products for Human Use (CHMP) had “recommended granting a conditional marketing authorization for the oral antiviral medicine Paxlovid for treating Covid-19 in adults who do not require supplemental oxygen and who are at increased risk of the disease becoming severe.”

Paxlovid is the first oral antiviral recommended in the EU for treating Covid-19. It consists of two active substances packaged together. One reduces the ability of SARS-CoV-2 to multiply in the body, while the other enables the first substance to remain longer in the body at levels that affect the multiplication of the virus.

The EMA said it had evaluated data from a study involving patients with COVID-19, which showed that treatment with Paxlovid significantly reduced the risk of hospitalization and death among patients with at least one underlying condition.

Most patients involved in the study were infected with the Delta variant of coronavirus. Based on laboratory studies, Paxlovid is also expected to be effective against Omicron and other variants, the EMA said, adding that the pill’s side effects were mild.

The EMA’s recommendation was sent to the European Commission for a rapid decision applicable in all EU member states.

ALSO READ: EU to sue China over Lithuania

Previous Story

Fake news about Nepal floods Chinese social media

Next Story

Nepal upset over China’s interference, Protests continue

Latest from -Top News

A new India-UAE cultural bridge

UAE and India reaffirm creative collaboration at New Delhi cultural roundtable, spotlighting the India House initiative and deepening ties through shared heritage, innovation, and artistic exchange…reports Asian Lite News The Embassy of

India skips Turkey’s national day celebrations

India pointedly skips Turkish National Day event amid tensions over Ankara’s pro-Pakistan stance; deepens engagement with Cyprus in parallel diplomatic outreach..reports Asian Lite News In a clear diplomatic signal reflecting the strain

EU leaders to be chief guests at R-Day

Move will be a historic first for India marking deepening ties amid global geopolitical shifts In a first for Indian diplomacy, New Delhi is set to invite the leadership of the European

Gazans Struggle to Revive Life

Today, Gaza’s markets seem to awaken from beneath the ruins. Partially destroyed shops opened their doors amid streets littered with debris, while merchants attempt to arrange what remains of their goods on
Go toTop

Don't Miss

Italians Urged To Join Covid Fight

In what was due to be his last New Year

Fully vaccinated Int’l students can return to Canberra in 2022

The international students who have been fully vaccinated against Covid-19